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ABSTRACT 
 
Background: The National Department of Health realised that its TB control efforts 
had been ineffective and joined its international counterparts by adopting Directly 
Observed Treatment short course [DOTs] strategy to fight the spread of TB. DOT is 
the only globally recognised strategy for effective TB control. This strategy ensures 
that infectious TB patients are identified and cured using standardised drug 
combinations. Treatment supporters observe patients as they swallow their drugs 
daily (SA Tuberculosis control Programme practical guide, 2000). 
Objectives of the study are: to assess the relevancy and quality of training for DOT 
supporters at InxubaYethemba and Tsolwana sub – districts,to identify challenges 
faced by TB DOT supporters during the execution of their duties and to assess 
satisfaction of TB DOT supporters, with their remuneration packages and other 
conditions of employment. 
Method: A quantitative descriptive convenient design was conducted for this study. A 
self - administered questionnaire was used.The researcher’s targeted sample was 
42 participants although only 39 filled in the questionnaires. The questionnaires were 
personally distributed by the researcher to TB DOT supporters. Items in the 
questionnaire included the following: Demographic data, working hours per day, 
distance covered, meeting with managers, salary and remuneration issues and 
acceptance by community members. 
Results: The research findings indicated that the TB DOT Supporters are generally 
not happy with the conditions they are working under. From the 100% (n=39) TB 
DOTS responses, 8% (n=11) received a three days training, which is not in line with 
the Department of Health’s guidelines,  and resulted in rendering  ineffective  
delivery  of DOT programme. Of the 100%) 23.1% (n=9) walk 8kilometres, 51.3% 
(n=20) walk 7kilometers, 12.8% (n=5) walk 5kilometers, 10.3% (n=4) walk 
4kilometers. This is against the required distance allowed to travel by foot which is 
five kilometres.   
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Conclusion:According the results of this study, the effectiveness of TB DOT 
Supporters is being distracted by many factors, such as: Not having transport for 
doing home visits, Less number of hours worked per day, few number of community 
health workers working as TB DOT supporters, not having meetings with the 
management to discuss their challenges, and most of all not being given a clear 
explanation as far as their salaries are concern. The mentioned factors render D OT 
Support programme is rendered in effective at the Chris Hani District. 
According to Tuberculosis, A training Manual proven for Health Workers (1998:13) 
the most effective means of controlling TB known to us is a strategy known as 
Directly Observed Treatment Short Course (DOTS). This strategy enables 
tuberculosis clients to complete their treatment and has four areas of strength when 
compared to previous TB control strategies in South Africa. 
Recommendation: The results from this study proves that there is a definite need for 
improvement of working condition amongst TB Co-ordinators, TB Managers and the 
TB DOT Supporters. It is clear that increased number of MDR/XDR is due to the 
challenges that were mentioned above. There is a need for the additional number of 
TB DOT Supporters, as the area is big for only two TB DOT Supporters in each area. 
Hours worked by TB DOT needs to be extended considering their salaries as 
well.Therefore it is essential to empower TB DOT Supporters with more knowledge 
and skills so that they can be able to make an impact in TB service delivery system. 
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CHAPTER 1 
1.1 Introduction and background 
The national Department of Health realised that its TB control efforts had been 
ineffective and joined its international counterparts by adopting Directly Observed 
Treatment short course [DOTs] strategy to fight the spread of TB. DOT is the only 
globally recognised strategy for effective TB control. This strategy ensures that 
infectious TB patients are identified and cured using standardised drug 
combinations. Treatment supporters observe patients as they swallow their drugs 
daily. (SA Tuberculosis control Programme practical guide, 2000) 
According to the National Tuberculosis Management Guidelines (2009:48) DOTS is 
an important element in the WHO recommended policy package for TB control. 
DOTS strategy is recommended for all clients for the entire period of treatment. It is 
impossible to predict who will or will not adhere to treatment and appropriate support 
mechanism should be put in place for all clients. This helps ensure that a TB client 
takes the right drugs, in the right dose, at the right times. In practice it means 
providing a treatment supporter that is both acceptable to the client and able to 
ensure completion of the treatment regimen. DOT may occur in the clinic, at 
workplaces or in the community 
1.1.1Clinic DOT system 
Clients who live close to a clinic should be encouraged to take treatment at the clinic 
if this is convenient for the client. During the first two months of the regimen 2, all 
clients require intra-muscular streptomycin and should therefore receive DOT at the 
clinic. The following measures are required to ensure effective clinic DOT system: 
daily medication collected through fast tracking that reduces waiting times, recording 
of daily doses taken on client held green cards, regular updating of blue clinic 
folders, putting systems in place to identify clients who did not present themselves 
for DOT on that day and to trace and recall them rapidly andputting a system to 
identify clients presenting for DOT who are also due for sputum collection.(SA 
Tuberculosis control Programme practical guide, 2000)  
 
2 
 
The reality is that for many clients clinic DOT is inaccessible, inconvenient, and 
costly and causes loss of income. Alternative methods of treatment supervision are 
necessary. 
1.1.2 Workplace DOT system 
Workplace DOT is beneficial to both employees and employers. TB clients usually 
require about two week’s sick leave at the start of treatment. After this period the 
client is non-infectious and most of the clients are able to return to work. For the 
employee, workplace DOT enables them to continue employment, and ensures 
continued income. The treatment supporter at the workplace could be an 
occupational health nurse, manager, supervisor, shop steward or other employee. 
Establishing workplace DOT requires: training of workplace treatment supporters, 
establishing systems that allow treatment to taken and monitored in privacy, 
confidentiality to be ensured, good communication with the clinic where the clinic is 
registered, allocating time for clinic visits so that medication can be collected, sputa 
provided for monitoring the response to the treatment and clinical evaluation 
undertaken (National Tuberculosis Management Guidelines 2009:48-49).  
1.1.3 Community DOT 
According to National Tuberculosis Management Guidelines (2009:48-49) 
Community DOT can contribute substantially to local TB Control Programme. It has 
the advantage of being more accessible and convenient to clients. A TB client who 
has far to travel for treatment is less likely to adhere to treatment, and community 
based DOT can be a viable alternative. The treatment supporter can be an existing 
community health worker or community member trained to provide DOT. 
Collaboration with other programmes allows the identification of health care workers 
that with suitable training and supervision can support TB clients. The approach in 
establishing community DOT should include: contacting the existing community 
groups and organisations,  determining how they might be able to contribute to the 
community TB care, involving community representatives in the selection of 
community treatment supporters and ensuring an appropriate geographic spread of 
treatment supporters, providing adequate initial training to DOT supporters on TB 
transmission, signs and symptoms, diagnosis, treatment, side effects and monitoring 
of response to treatment, addressing ethics and confidentiality, establishing standard 
operating procedures and systems for administering daily medication and monitoring 
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adherence, including completion of the client owned green card when doses are 
taken and methods for identifying those interrupting treatment. 
The DOT supporters should follow  up and take a record of defaulters, communicate 
and give feed back to the clinic, reminding clients about the sputa that are due during 
the course of treatment, keeping records at the clinic indicating the location of 
treatment supporters and clients allocated to them [National Tuberculosis 
Management Guidelines 2009:48-49].  
The introductory training of the selected TB DOT supporters varied according to the 
different sites and ranged from five days to five weeks. TB Manager is the one who 
is responsible for the training of TB DOT Supporters. Training covered the principles 
of becoming a TB DOT supporter, details about TB as an illness, HIV/AIDS and 
health aspects of hygiene and nutrition. There is also an emphasis on self-care, 
dealing with conflict and issues to do with communication. Training continues as the 
DOT supporter is supervised and supported in his/her role by the person 
coordinating the intervention. The contact is monthly and generally occurs when the 
DOT supporter obtains the supply of medication (Murrey and Botha, 2005). 
Community Health Workers at the treatment centres are trained on the current 
issues on TB and its treatment, overview of the DOT strategy, community education, 
how to take sputum samples, how to observe treatment, and how to keep records. 
Training courses are about three to six days long at District level (Health link 
worldwide, 2001). 
Curing TB is an important process which takes at least 6 months of drug treatment. 
Multiple drug resistant (MDR) TB can develop when patients do not finish their full 
course of treatment, sometimes they stop because they feel better after first few 
months. People who develop MDR TB can spread it to others easily as regular TB 
(TB in SA, the people’s plaque 2006).  In South Africa it is estimated that there are 
200 new MDR TB patients every year. The drugs to treat one MDR TB patients cost 
R25 000 as opposed to the R250 it costs for drugs to treat a new infectious TB 
patient. The treatment period of MDR TB is 18 to 24 months as opposed to the 
6months for ordinary TB (Advocacy Publication, 1998-1999). 
4 
 
Directly Observed Treatment Short course has been promoted a global strategy 
since the mid 1990’s. It was launched in Pakistan in 1995 (Ali, 1998: 524).South 
Africa began the process of implementing the DOT country wide in November 1996.   
1.2 Reasons for dots strategy 
According to Tuberculosis, a Training manual for Health Workers, 1998, it is said that 
there is no other TB control strategy that has consistently demonstrated such a high 
cure rate as the Dots Strategy. The cure rates can be as high as 95% even in poor 
countries with fewer resources. Without DOTS the cure rates are very low at40% 
and lower. Dots programme provides effective TB cure by ensuring regular taking of 
medication as prescribed. The uninterrupted treatment observed through DOT is the 
best way of preventing TB bacilli developed resistance. MDR TB is caused by taking 
anti TB drugs irregularly. Community based DOTS is cheaper than the cost of 
hospitalisation patients for all or some of their course of treatment. 
 
1.2.1 Advantages of dots strategy 
It is clear that MDR TB should be prevented at all costs,andthe only way is through 
DOTS strategy. DOTS do not require expensive hospitalisation nor technology and a 
new health structure as TB control programme can be easily integrated in an existing 
primary health care system. Dots Strategy extends the lives of AIDS patients by 
making it easier for them to be cured. By treating and curing the TB in HIV-positive 
patients, many years can be added to their lives. According to the Tuberculosis 
Training manual for Health Workers, (1998) the presence of DOTS supporters in the 
workplace, means that TB patients can continue working. Nearly 80% of patients are 
in their most productive years of life, without the DOTS strategy to cure patients, the 
TB epidemic will continue to burden the workforce (Tuberculosis a Training manual 
for Health Workers, 1998). The DOTS strategy assists the economy of developing 
countries by allowing patient to continue working. Studies in India and Thailand have 
shown that a small investment in the DOTS strategy can save their economy, billions 
in US dollars. DOTS strategy was pioneered 10 years ago. It has been successfully 
implemented under various conditions in Tanzania, China, Bangladesh, New York 
City and Peru Nearly 70 countries worldwide have implemented DOTS with good 
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results. In 1996, approximately one million TB patients were treated with DOTS 
supporter (Tuberculosis a Training manual for Health Workers, 1998). 
The above report represents reflection on South African supporters of DOTS, and 
the international recommended strategy for TB control. The DOT strategy has been 
implemented on national level in South Africa’s fight against TB, and DOT supporters 
are lay health workers who provide some of the service called for by the strategy. 
1.3Problem statement 
The increase in TB defaulters and the resultant MDR infection is observed in Inxuba 
YethembaTsolwana sub-districts under Chris Hani Municipality, in the Eastern Cape. 
Even though the DOT Support system was instituted in November 1996, there has 
been little improvement in TB cure rates at the Inxuba Yethemba sub-district. The 
available Community Health Workers (DOT) Supporters are too few and not able to 
reach all TB sufferers to assist them to adhere to the TB treatment. 
Although treatment of tuberculosis has been available free of charge in our local 
clinics, the disease is still among the leading causes of death, which in turn are 
caused by the delays in detection and treatment as well as patient adherence to 
treatment. The increase in TB prevalence rate is also due to the increasing HIV 
epidemic, the number of TB cases is also increasing because of failures in existing 
treatment strategies for TB (Health link worldwide, 2001).There is a need for 
strengthening the TB programmes by increasing the number of Community Health 
Workers visiting TB patients on TB treatment at home to assist TB suffers to adhere 
to their treatment. 
1.4 Purpose of the study 
The purpose of the study is to describe and explain the perceptions of TB DOT 
supporters at InxubaYethemba and Tsolwana sub-districts in Chris Hani District in 
the Eastern Cape  
1.5 Objectives 
To assess the relevancy and quality of training for DOT supporters at 
InxubaYethemba and Tsolwana sub-districts.  
To identify challenges faced by TB DOT supporters during the execution of their 
duties. 
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To assess satisfaction of TB DOT supporters with their remuneration packages and 
other conditions of employment. 
1.6 Research questions 
Is the TB DOT support system effective in the improvement of adherence to TB 
treatment? 
What are the challenges encountered by TB DOT supporters? 
Is the increase in TB defaulters caused by fewer TB DOT supporters? 
1.7 Significance of the study 
The results and recommendations from this study will assist the TB programme 
planners in the improvement of TB delivery service within the Eastern Cape 
Province. The recommendations from this study will assist DOT supporters  with  
knowledge and skills to render service that is of good quality to the TB patients on 
treatment. 
1.8 Definition of terms 
DOT strategy: is a patient centred approach which provides support for TB clients 
by observing them as they swallow their TB drugs and to ensure that they complete 
their treatment (Faces of TB, TB Advocacy Publications, and 1998-1999).In this 
study DOT strategy refers to the strategy used by DOT supporters at Chris Hani 
district. 
Directly Observed Treatment Short-course(DOT): This strategy ensures that 
infectious TB patients are identified and cured using standardised drug 
combinations. Treatment supporters observe patients as they swallow their drugs 
daily (SA Tuberculosis control Programme practical guide, 2000). 
DOT Supporter according to SA Tuberculosis control Programme practical guide, 
(2000) a DOT Supporter is a person who directly observed a patient while taking 
treatment. In this study DOT is referred to Community Health Workers who are 
functioning as TB DOT supporters. 
Effectiveness: According to the Concise Oxford Dictionary, means having a definite 
or desired effect. In this study effectiveness refers to the effectiveness of the DOT 
service programme rendered by community health workers, working as TB DOT 
supporters   
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1.9 Summary 
In this chapter, the researcher has discussed the history and the background of TB, 
giving the reader a clear picture of how to manage TB using DOTs programme. The 
following has also been discussed, the advantages of DOT programmes, problem 
statement, purpose of the study, objectives, research questionnaire, significance of 
the study and the definition of terms. 
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CHAPTER 2 
Literature review 
2.1 Introduction 
A literature study is the focused attempt to become familiar with what has been done 
in the area from documented information. The review of literature involves the 
systemic identification, location and analysis of document containing information 
related to the research problem. It is all the written sources relevant to the topic of 
interest (Brink 2009; 67). 
In the previous chapter an overview of the dissertation was given on aspects 
pertaining the control of TB, such as research done on TB as a health problem and 
the DOTS strategy as a possible solution to the problem. In this chapter literature 
review will be discussed under the following headings:  Tuberculosis as the health 
problem, Multi Drug Resistant/ Extreme Drug Resistant, Factors contributing to MDR 
TB, Client related, The primary Health Care role in MDR TB Management, 
Preventing MDR TB, Management of TB, New cases Re treatment cases, 
Integration of TB and HIV, Epidemiology of TB and HIV, Impact of TB on HIV and the 
conclusion.  
2.2Tuberculosis as a health problem 
Tuberculosis remains the most important communicable disease in the world. In  
South Africa it accounts for over 80% of all notifiable disease. It arrived in this 
country with colonialists, settlers and missionaries, many of whom were already 
infected from the massive epidemic, which had swept Europe and North America 
during 17 century. Many sufferers came seeking a cure from the sun and fresh air. 
The previously unexposed non-immune indigenous population of South Africa rapidly 
developed TB (Edginton, 2000:10). 
When the gold mines started on the Reef in the later 1800s, workers were exposed 
to silica dust, overcrowded hostel living, poor nutritional status and stress, all of 
which were major contributors to the development of TB. When they become sick 
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they return back home to their families in rural areas and spread the disease to 
them. By 1930 it was estimated that over 60% of black population was infected. In 
1953 the rate of active disease was measured to be 780 per 100 000 of the 
population of the Northern and Eastern parts of the country (Edginton, 200:10). 
In 1993, the World Health Organisation (WHO) declared tuberculosis as a 
globalemergency. According to WHO, worldwide incidence of tuberculosis (TB) may 
have peaked in 2005. Tuberculosis infection is responsible for more deaths than any 
other infectious disease. Once called consumption, TB is a highly contagious, 
persistent disease characterised by the formation of hard greyish nodules or 
tubercles, because its signs and symptoms are easily confused with those of many 
other disease like respiratory tract infections,it can be difficult to diagnose (WHO 
2005:1) 
Tuberculosis (TB) is a common, and in many cases, a lethal infectious disease 
caused by various strains of mycobacterium, usually Mycobacterium Tuberculosis. 
Tuberculosis usually attacks the lungs but can also affect other parts of the body. It 
is spread through the air when people who have an active MTB infection cough, 
sneeze or otherwise transmit their saliva through the air(Smeltzer, Bare, Hinkle, 
&Cheever,2010:567). 
According to a clinical manual by Harries, (1997:19) TB is a bacterialdisease caused 
by Mycobacterium tuberculosis (and occasionally by Mycobacterium bovis and 
Mycobacterium africanum). These organisms are also known as tubercle bacilli, 
because they cause lesions called tubercles, or as acid fast bacilli [AFB] It is said 
that when examining sputumcontaining tubercle bacilli stained with certain dyes 
under the microscope, the bacilli looks red. This is because they are acid fast. 
The natural history of tuberculosis was described in the early nineteenth century by 
the French physicians Gaspard Laurent Bayle and Rene Laennec, both of whom 
died from the disease. Bayle, by his detailed pathological studies, put the 
investigation of tuberculosis on a firm scientific basis, while the invention of the 
stethoscope by his close friend Laennec in 1816 facilitated detailed descriptions of 
the clinical signs of the disease in the human lung ( Pratt and John  2005:2) 
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Schaaf and Zumla (2009:17) describe tuberculosis as a rare disease, whose 
prevalence is measured or estimated in cases per 100,000 population. They also say 
that it is a slow moving disease, the time scale of epidemics is decades rather than 
weeks or years. 
Exposure to an individual with active pulmonary TB carries a substantial risk of 
acquiring infection. In household contacts of TB cases this risk is approximately 
25%, although it can be higher if exposure is more prolonged in sustained closed 
quarters. Inhalation of micro droplets containing MTB may result in infection. 
Whereas large droplets are deposited in the upper airway [trachea and bronchi], and 
removed by mucocilliary clearance mechanism, smaller droplets that contain three or 
fewer bacilli may reach the alveoli(Friedman, 2001:20). 
2.3Multidrug Resistant / Extreme drug Resistant TB 
On the 5th of September 2006, in Geneva, the World Health Organisation [WHO] has 
expressed concern over the emergence of virulent drug resistant strains of 
tuberculosis, and is calling for measures to be strengthened and implement to 
prevent the global spread of the deadly TB, a newly identified TB threat which leaves 
patients virtually untreatable using currently available anti-TB drugs (Thomas and 
Weyer, 2006). 
According to a Training Manual for Health Workers, (1998:59) Multidrug Resistant 
TB [MDRTB] describes strains of tuberculosis that are resistant to at least two main 
first line TB drugs that is isoniazid and rifampicin. MDR-TB develops during 
treatment of fully sensitive TB when the course of antibiotics is interrupted and the 
levels of drug in the body areinsufficient to kill 100% of bacteria. This can happen for 
a number of reasons: patients may feel better and halt their antibiotic course, drug 
supplies may run out or become scarce, or patient may forget to take their 
medication from time to time 
Extensive drug resistant TB [XDR-TB] also referred to as Extreme drug Resistant TB 
is MDR TB that is resistant to three or more of the six classes of second line drugs. 
Some contend that XDR TB strains have emerged from the mismanagement of 
multidrug resistant TB, and once created, can spread from one person to another. 
The exact nature of this mismanagement is not yet known, but the origin of XDR-TB 
may coincide with the institution of new policies to promote drug compliance, such as 
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DOT. According to the National TB Management Guidelines (2009: 87) XDR TB is 
extremely difficult and expensive to treat. It has very high mortality, with rates of over 
90% recorded amongst HIV co- infected XDR clients in Tugela Ferry KwaZulu Natal 
Since the mid-eighties, cases of MDR-TB have been diagnosed in each of the nine 
provinces in South Africa. WHO estimates an MDR rate of 1.8% in new TB cases 
and 6.7% in previously treated cases in South Africa, with approximately 8000 new 
MDR-TB cases each year. MDR-TB is expensive to treat. The social and economic 
burden of this problem is already evident in South Africa where the cost of treating a 
case of MDR-TB is up to 25 times the cost of treating an uncomplicated, drug 
susceptible case. It is therefore of utmost importance that MDR-TB be prevented by 
rigorous adherence to the principles of the National Tuberculosis Control Program, 
and by building partnerships with clients, their families and communities to cure 
cases of tuberculosis at the first attempt (National Tuberculosis management 
Guidelines, 2009:82). 
2.3.1 Factors contributing to MDR-TB 
As with other forms of drug resistance, MDR tuberculosis is a man-made problem 
being largely the consequence of human error in any, or all of the following: frequent 
or prolonged shortages of first line Anti tuberculosis drugs due to poor stock 
management and/or procurement problems, use of tuberculosis drugs or drugs 
combinations of unproven bioavailability, the use of single first line drugs rather than 
fixed-dosed combination tablets. 
 Poor client management is due to health system failures that lead to poor 
management of clients on first line regimens, inadequate or inappropriate treatment 
and poor adherence, including poor relationships between clients and health care 
personnel due to the uncaring staff attitudes, all contribute to MDR-TB.  Little 
empathy for clients, being paternalistic and failing to adopt a problem solving 
approach to help resolve issues all contribute to poor adherence. Inadequate 
counselling of clients, result in low knowledge levels, poor understanding of what is 
expected of them, and of the importance of completing treatment results in poor 
adherence. Poor monitoring of the response to treatment, ineffective systems, 
including lack of support for directly observed therapy and unsupervised clients also 
contributes in this regard. Poor record keeping, follow up of clients and referral, 
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staffing issues including frequent staff changes, poor staff morale, lack of regular 
support and supervision and low accountability of staff for programme outcomes also 
contributes to poor adherence to first line regimens (National Tuberculosis 
Management Guidelines, 2009:82-83). 
Prescription errors including: the use of two or three drugs when four or five first line 
drugs should be used, adding one extra drug to a failing regimen, insufficient contact 
tracing and follow up of MDR cases also contribute to the spread of MDR-TB. 
 
2.3.2 Client- related Factors 
Client adherence is most often a problem when the client is homeless, has an 
alcohol or drug problem, and is unemployed and /or looking for a job,afamily member 
has been unsuccessfully treated previously, and when access to health care is 
difficult (National Tuberculosis Management Guidelines, 2009:82-83). 
2.3.3 The Primary Health Care role in MDR TB management 
Although the specialist MDR units in each of the provinces have the key 
responsibility for MDR TB, primary health facilities have an essential role to play in 
preventing MDR TB by implementing effective TB control and reducing the likelihood 
of resistance developing, ensuring early diagnosis of potential MDR in clients who 
fail to respond to regimen one and two, assisting with MDR contact tracing, providing 
on going care post discharge from the MDR units and liaising with the MDR unit, 
providing counselling and support to MDR clients, families and contacts. 
2.3.4Preventing MDR TB 
Preventing the development of drug resistance requires cooperation of all TB 
treatment providers, including the private health sectors, in implementation of TB 
programme policies, provision of the right drugs, in the right dosage for the correct 
period of time, ensuring good adherence to treatment, adequate counselling of 
clients and their families, accessibility of services , addressing barriers to adherence 
e.g. appropriate referral to social services, supervision and monitoring of adherence, 
use of fixed drug combination tablets, uninterrupted drug supply, an ensuring a four 
months stock at a facility level, early diagnosis of MDR, prompt initiation of effective 
treatment and contact tracing and screening. 
13 
 
2.4 Management of TB 
The next major breakthrough in the therapy of tuberculosis came in the late 1960’s, 
with the discovery of rifampicin or rifampin, as it is known in the USA.This drug made 
it possible to develop orally administered regimens lasting the much shorter time of 
six months. Although a six months therapy is  very long compared with courses of 
antibiotics for many acute infections, it is considerably shorter than the former 18-24 
months, and is therefore called “short-course therapy” (Pratt et al., 2005:152). 
Since 1970, therapy has been shortened from 18 months of isoniazid and 
ethambutol to 9 months of isoniazid and rifampicin,and then to the current 6 months 
regimen. This was due largely to the introduction of rifampin, and the addition of 
pyrazinamide (Friedman, 2001:116). According to the South African TB control 
programme, (1996:8), clients are supposed to take treatment five days a week, 
Monday to Friday, It is said that no treatment is needed on Saturday and Sunday. 
Three times per week regimens should be taken in the continuation phase. A new 
recommendation was made in 2009, that the TB treatment should be taken every 
day for seven days, including Saturday and Sundays. 
2.4.1 New TB cases 
According to the National Tuberculosis Management Guidelines, (2009:37) a new TB 
client is a client who has never been treated for TB in the past or who has taken TB 
treatment for less than four weeks. The standard treatment regimens for new cases 
have an initial or intensive phase lasting for two months and a continuation phase 
lasting four months. Treatment with four drugs (isoniazid, rifampicin, pyrazinamide 
and ethambutol) in the intensive phase results in rapid killing of tubercle bacilli. 
Infectious clients become non-infectious within approximately two weeks. The 
majority of clients with sputum smear positive TB become smear negative within two 
months. In the continuation phase, two drugs (isoniazid, rifampicin) are used, but for 
a longer period of time. The effect of the drugs eliminates the remaining bacilli and 
prevents subsequent relapse (National Tuberculosis Management Guidelines, 
2009:37). 
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Table 1 Regimen1 (New Cases) for adult and children> 8 years 
Pre-treatment body 
weight 
Intensive phase 
7 days a week for 2 
months 
Continuation  
Phase 
 
 RHZE 
(150,75,400,275) 
RH 
(150, 75) 
RH 
(300, 150) 
30-37kg 2tabs 2tabs  
38-54kg 3tabs 3tabs  
55-70kg 4tabs  2tabs 
>70kg 5tabs  2tabs 
(National Tuberculosis Management Guidelines, 2009:37)  
2.4.2 Re-treatment cases 
Re-treatment cases  include all TB clients who were treated for four weeks or more 
in the past and who are now smear or culture positive, or who have clinically been 
diagnosed with TB (failure, relapse, return after default). 
These cases have a higher likelihood of resistance that may have been acquired 
through inadequate prior chemotherapy. The retreatment regimen has an intensive 
phase lasting three months. For the first two months, treatment includes five drugs: 
(isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin). In the third 
months, treatment is with four drugs: [isoniazid, rifampicin, pyrazinamide and 
ethambutol.]The continuation phase with three drugs [isoniazid, rifampicin and 
ethambutol] lasting for five months. This regimen can cure clients excreting bacilli 
still fully sensitive to the drugs as well as those excreting bacilli resistant to the 
isoniazid and or streptomycin. Under proper case management conditions, MDR-TB 
cases are those most at risk of failure on the treatment regimen  
(National Tuberculosis Management Guidelines, 2009:37). 
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Table 2 Regimen 2 (Re treatment cases) for adults and children >8years 
Pre 
treatment 
body 
weight 
Intensive Phase 
 
7 days a week for 2 months 
3rd month  
7days a week 
Continuation Phase 
 5months7days a week  
 RZHE 
150,75,400,
275 
Streptomycin 
(g)* 
RZHE 
150,75,400,275 
RH 
150,75 
E 
400 
RH 
300,15
0 
E 
400 
 
30-37kg 2tabs 0.5 2tabs 2tabs 2tabs    
38-54kg 3tabs o.75 3tabs 3tabs2tab
s 
2tabs    
55-70kg 4tabs 1.0 4tabs   2tabs 3tab
s 
 
>71kg 5tabs 1.0 5tabs   2tabs 3tab
s 
 
(National Tuberculosis Management Guidelines, 2009:37)  
2.5 challenges to TB control 
We face several challenges to improving TB control: 
 Inadequate financial and human resources for the TB control programme  
 characterised by low level of awareness of TB, poor health seeking behaviour 
amongst symptomatic people resulting in late presentation to health facilities 
and inadequate community support for those on TB treatment; 
 Inadequate health systems that result in low case detection, poor continuity of 
care and high levels of treatment interruption; 
 Poorly trained or supervised health care personnel, low levels of 
accountability of health care personnel, non-adherence to protocols, poor 
record keeping and poor relationships with clients; 
 Low levels of integration of TB and HIV services at patient management level. 
 The numbers of MDR- TB and XDR-TB cases have been increasing. 
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The management of drug resistant TB at facility level is sub optimal, with inadequate 
early pick up of resistance and poor follow up of MDR TB clients discharged from in-
patient facilities. (National Tuberculosis Management Guidelines, 2009:10)  
 
2.6 Integration of TB and HIV 
The many interactions between tuberculosis and human immunodeficiency virus 
infection influence the design and implementation of programmes to address the 
needs of patients living with or at risk for both diseases. Collaboration between 
national TB and HIV programmes and some degree of integration of services at a 
local level have been advocated by the WHO and other international bodies, and are 
recognised as essential in areas where the two diseases are prevalent. TB/ HIV 
service integration are instructive, illustrate common themes, and show that the 
strategy can be successful, but they also show that the programmatic, medical, 
staffing resources, and scale up challenges remain. In addition, they indicate that, 
although broad programme principle of TB/HIV service integration are essential, 
programme designs and components may vary by country and even within countries, 
as a result of differing  TB and HIV diseases prevalence(Journal of Infectious 
Disease, 2007, vol196) 
According to Pratt, et al.,(2005: 132) most people who overcome a primary infection 
by the tubercle bacillus have about a 5 percent risk of developing post primary 
Tuberculosis at some time during the risk of their lives, but in a person co-infected 
with HIV, the risk is around 8 percent each year. Thus the annual risk of a co-
infected person developing tuberculosis is more than 20 times higher than that of 
someone infected by the tubercle bacilli alone. Historically, most cases of 
tuberculosis in adults are ascribed to re activation of endogenous infection, but the 
use of fingerprinting has shown that many cases of new and recurrent tuberculosis 
are due to recent infection. This is particularly the case in HIV infected individuals 
owing to their lowered ability to prevent infection progressing to active disease. On 
the other hand patients with HIV related tuberculosisis no more infectious than those 
who are not infected with HIV (Pratt, Grange et al., 2005:132). 
HIV infection leads to progressive immunodeficiency and increased susceptibility to 
infections including TB. As HIV infection progresses, CD4 lymphocytes decline in 
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number and function. The immune system is less able to prevent the growth and 
local spread of Mycobacterium tuberculosis, leading to the progression of resent or 
latent TB infection to active TB disease. In the absence of HIV infection, only about 
10% of people infected with Mycobacterium Tuberculosis get sick with TB during 
their life time. In people with HIV, about 50% will develop active TB disease at some 
stage. Currently 55% of TB clients are co infected with HIV in South Africa. The high 
levels of active TB in persons living with HIV/AIDS poses an increased risk of TB 
transmission to the general community (National Tuberculosis Guidelines, 2009:73). 
HIV not only increases the number of TB cases but also alters the clinical course of 
TB disease. Although tuberculosis can occur at any point, in the course of 
progression of HIV infection, the clinical pattern of disease changes. As HIV related 
immune suppression increases, there are increasing number of smear negative 
pulmonary TB, extra pulmonary TB and cases of disseminated TB. TB is also more 
difficult to diagnose as immune suppression progresses. Co-infected clients have an 
increased mortality due both to late diagnosis and other opportunistic infections 
(National Tuberculosis Guidelines, 2009:73). 
TB is the most common, serious and life threatening opportunistic infection in people 
with HIV and AIDS in Africa and in other developing countries. Since the beginning 
of the HIV/AIDS epidemic there has been a steady increase in the number of new TB 
cases. The TB epidemic has shown a parallel riseapproximately 50-60% of people 
with HIV infection will develop active TB disease at some stage of their disease. This 
means that there is a 10 times increase risk of developing TB if a person is HIV 
positive. In many parts of South Africa and Africa, the prevalence of HIV among 
people with active TB is almost 50%. This means that, a patient with TB is also very 
likely to have HIV infection. Patients with HIV and TB are referred to as dual or co-
infected (Evian, 2003:243). 
TB is treated the same way in HIV infected and HIV uninfected individuals, care must 
be taken when treating HIV and TB concomitantly because of interaction between 
anti-TB and antiretroviral drugs. Treatment with antiretroviral drugs can lead to 
immune reconstitution inflammatory syndrome with those co-infected with TB and 
HIV (Karimand Karim,2005:433). 
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2.7 Epidemiology of TB and HIV 
Globally, around 12 percent of all cases of tuberculosis are now HIV related. At the 
present time the impact of the HIV epidemic on tuberculosis is most  severe in sub 
Saharan Africa, where in the last decade of the twentieth century, almost a quarter of 
the estimated 15 million new cases of tuberculosis were HIV related. As a direct 
consequence, the prevalence of tuberculosis doubled, trebled or even quadrupled in 
some African countries over this time period 
In Zambia for example, the prevalence of tuberculosis was fairly constant between 
1964 and 1984, around 7000 new reported cases annually. In 1995, however, 40 
000 new cases were reported and three quarters of these were HIV related. 
Depending on the country, between 20 and more than 70 percent of cases of 
tuberculosis in sub Saharan Africa are HIV related. Tuberculosis is foremost among 
the causes of maternal death in Zambia, where one in four pregnant women are HIV 
infected. At present, the greatest impact of HIV on tuberculosis is seen in Africa, but 
the population size (around 750 million in 1998) is relatively small compared to that 
of the India subcontinent, China and south East Asia. Most of the world’s cases of 
tuberculosis occur in these more highly populated regions, where unless the present 
upsurge of HIV infection is controlled, there could be serious tuberculosis problems 
in the near future(Pratt et al, 2005:132). 
In 1995, about one third of the 17 million HIV infected people worldwide were also 
co-infected with Tuberculosis. 70% of co-infected people lives in sub Saharan Africa, 
20% in Asia and 8% in Latin America and the Caribbean (TB/HIV A clinical manual, 
1996:29).South Africa has the highest number of HIV infected and the eighthhighest 
burden of incident TB of any country worldwide. About two million South Africans are 
MTB/HIV co-infected, and the estimated incidence of all forms of TB was 509 per 
100 000 population for 2002. Of these 60% of adult cases are also HIV infected 
(Karim et al., 2005:434). 
 
2.7.1 Impact of TB on HIV 
The impact of TB on the progression of HIV infection has been recognised widely. 
However, to date, this effect is most notable inAfrica, where 12 of the 15 million co-
infected patients have originated. Since the response of HIV infected TB patients to 
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antituberculosis drugs is similar to HIV unaffected TB patients, the increased 
morbidity and mortality in co-infected patients is attributable to the worsening of HIV 
disease.  For example, in Uganda the mortality of TB in HIV infected patients is 30%, 
this finding has been found to be due primarily to progressive HIV disease, and not 
to the tuberculosis disease(Friedman,2001:36). 
TB and HIV also have an interaction at the cellular level. TB disease leads to 
immune activation and increases viral replication, and it has been postulated that this 
could result in an accelerated progression of HIV disease, or a period of increased 
infectivity. The question of whether TB accelerates HIV progression has been 
studied extensively, but the clinical significance is still not clear. A number of 
observational studies have shown that HIV infected patients who develop TB have a 
worse prognosis than HIV infected patients who have been staged at a similar level 
of immune suppression but remain free of TB disease (Karim et al.,2005:438). 
However, staging HIV is not very precise and it is difficult to reconcile this hypothesis 
with the lack of impact on survival reported by most TB preventive trials. Prospective 
studies measuring viral load before and after an episode of TB support the review 
that intercurrent TB indicates profoundly impaired immunity rather than being the 
cause of it(Karim and Karim, 2005:438) 
 
2.8 Directly observed treatment short course (DOTS) 
DOTS is the name for a comprehensive strategy which primary health services 
around the world are using to detect and cure TB patients. It means that someone 
supports the patient by actually observing that the pills are taken on a daily basis. 
DOTS is best way to help patients take all their treatment.It depends on four 
elements. D- DIRECTLY- The first priority of the NTCP must be to direct resources 
towards detecting sick, infectious TB cases, so they can be cured (Tuberculosis, A 
Training Manual for health workers, 1998:63) 
In the 1980’s, at the time of the closure of the British medical Research Council’s 
Tuberculosis and chest diseases  Unit, ominous trends including the impact of HIV 
infection, were inducing many expects to challenge the prevalent complaicement 
assumptions of complaicency. Accordingly, by the early 1990’s, the WHO was re 
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establishing very serious interest in Tuberculosis. This renewal of interest led, in 
1993, to the unprecedented declaration by the WHO that Tuberculosis was a global 
emergency. This was no empty slogan, as it heralded a period of intense advocacy 
and activity (Pratt, et al., 2005:170). 
As a direct consequence, in 1998, the global plan to stop Tuberculosis was launched 
in Bangkok and rapidly grew into an extensive network of numerous governmental, 
nongovernmental and academic organisations with a secretariat based at the WHO 
headquarters in Geneva. The basis of the Global Plan to Stop TB programme is the 
WHO DOTS strategy. DOTS is an acronym of Directly Observed Treatment Short 
course, and is the brand name of a five point control strategy formally introduced in 
1994 ( Pratt et al.,2005:170). 
The technical strategy for DOTS was pioneered by DR Karen Styblo, a greatly 
respected epidemiologist and physician who for many years worked for the 
International Union against Tuberculosis and Lung Disease, in the 1980s, primarily in 
Tanzania. In 1989, the World Health Organisation and the World Bank began 
investigating the potential expansion of this strategy. In July 1990, the World Bank, 
under RichardBumgarner’s direction, invited Dr StybloandWHO to design a TB 
control project for China. By the end of 1991, this pilot project was achieving 
phenomenal results; more than doubling cure (Tuberculosis Management Guidelines 
2009:48) 
According to Schaaf and Zumla (2009:23) in Peru DOTs was launched in 1991, and 
high rates of case detection cure pushed down the incidence rate of pulmonary TB 
by six% per year. Indirect assessments of the effect of DOTs suggest that 70% of 
the TB deaths expected in the absence of DOTs were averted in Peru between 1991 
and 2000. 
The political implications of the use of the brand name for promoting the DOTS 
strategy for global tuberculosis control have been critically analysed by Ogden and 
her colleagues. The strategic objectives of the Global Plan to Stop TB are: To 
expand the DOTS programme so that eventually all those with TB will be effectively 
diagnosed and treated, adapt the programme to face the challenges of HIV related 
tuberculosis and multidrug resistance, improve the control of the disease by 
developing new diagnostic tests, drugs and vaccines and to strengthen the 
21 
 
partnership so that the control strategies are effectively applied(Pratt, et al., 
2005:170). 
According to the National Tuberculosis Management Guidelines,( 2009:48)Directly 
Observed Treatment is an important element in the WHO recommended policy 
package for TB control. It means that an observer (treatment supporter) watches the 
client swallowing the tablets, in a way that is sensitive and supportive to the client’s 
needs. Close supervision and monitoring of clients allows good monitoring of 
adherence and early pick up of non-adherence and adverse drug effects.  
According to the National Tuberculosis Management Guidelines, (2009:48)DOT is 
recommended for all clients for  theentire period of treatment. It is impossible to 
predict who will or will not adhere to treatment and appropriate support mechanisms 
should be put in place for all clients. This helps ensure that a TB client takes the right 
drugs, in the right doses, at the right time. In practice, it means providing a treatment 
supporter that is both acceptable to the client and able to ensure the completion of 
the treatment regimen. DOT may occur in the clinic, at work place or in the 
community. The treatment supporter may be a health worker or a trained workplace 
or a community member.  
2.8.1 Key elements of DOTS strategy 
The key elements of DOTS strategy are: 
Government commitment to sustain TB control activities;Sputum smear microscopy 
to detect the infectious cases among those people attending health care facilities 
with symptoms of TB, most importantly cough of three weeks duration or more 
standardised short course anti TB treatment for at least all confirmed sputum smear 
positive pulmonary TB cases, with direct observation of treatment for at least  the 
initial two months; A regular, uninterrupted supply for all essential anti TB drugs; A 
standardised recording and reporting system which allows assessment of treatment 
results and overall programme performance (South African TB control Programme, 
2000:38). 
The benefits of DOTS strategy are thus well established, and the huge challenge 
facing the global community is to ensure that all patients with Tuberculosis have 
access to diagnosis and treatment within this strategy. In March 2000, in the so 
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called Amsterdam Declaration to stop TB, the targets of diagnosing 70 percent of 
sputum smear positive patients and curing 85 percent of those diagnosed by the 
year 2005 were set. An additional target is to reduce the global burden of 
tuberculosis, in terms of prevalence and death rates, to half of its year in 2000 level 
by 2005 ( Pratt, et al., 2005:171). 
According to Davies (1998:480-481) DOTS has clearly been shown to have the 
potential to significantly improve tuberculosis control in different parts of the world. 
However, it remains untested in some of the environments in which control is most 
urgently needed, namely, where infrastructures are fragile or situations are unstable 
as exemplified by the extreme conditions experienced by displaced populations. 
Davies (1998:4881) further says, there appears to be potential for DOTS 
implemented at the community level to improve care generally, but whether it will 
have a significant impact on equity remains to been seen. We have discussed how 
community based DOT has been assessed to cost effective both from the perceptive 
of the health system and the patient. Cost to the community, which maybe providing 
an increasing number of DOT Supporters at no avert financial charges have yet to 
be taken into account. DOT in the community may well hold the key to successful 
tuberculosis control globally, but there is an urgent need for social assessments of its 
place in those parts of the world where it is most urgently needed (Davies, 
1998:481). 
2.9Summary 
 From the literature review conducted, it is evident that TB is not a South African 
Problem, but it is a global health issue that needs to be dealt with aggressively. The 
use of DOT strategy is seen as the possible solution to fight TB worldwide. 
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CHAPTER THREE—METHODOLOGY 
3.1 Introduction 
This chapter describes the steps taken to achieve the study objectives. These steps 
include the type of study design chosen, study setting, selection of respondents, 
sampling, and research questions used in the questionnaires, validation of 
questionnaires, the ethical consideration and data analysis. 
3.2Research questions 
The research questions of this study were based on the study aim and objectives as 
outlined in chapter one.  The research questions are as follows:  
Is the TB DOT support system effective in the management of TB infection among 
the sufferers?  
What are the challenges encountered by TB DOT supporters?  
Is the increase in TB defaulters caused by fewer TB DOT supporters? 
3.3 Study design and approach 
The researcher used a nonprobability quantitative approach and a descriptive design 
for this study. A research design is a structure or framework within which data is 
collected. The function of a research design is to ensure that the evidence obtained 
enables us to answer the initial questions as unambiguously as possible (Becker and 
Brayman, 2009:186).This design was deemed appropriate for this study since the 
researcher was interested in understanding the effectiveness of TB DOT supporters 
as perceived by them. 
 
3.4 Study setting 
This study is based on the population of Home Based Carers, who are working as 
TB DOT supporters. These TB DOT supporters are working in different clinics, at 
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InxubaYethemba and Tsolwana Sub-Districts in the Chris Hani Municipality, in the 
Eastern Cape. In each clinic, in InxubaYethemba, Tsolwana Sub - Districs, within the 
two mentioned sub districts there are 21 fixed clinics. In each clinic there are two 
community health workers working as DOT supporters. Each DOT supporter is 
serving a vast area of the catchment population.  InxubaYethemba sub- district has 
an average of 336 TB patients. In one clinic there are 97 clients on TB treatment and 
there are 40 TB patients who are supervised by DOT supporters.  All the clinics are 
serving patients suffering from TB and on TB treatment.  Some of the patients are   
given their TB treatment by the nurse at the clinic. There is no transport provided for 
TB DOT supporters, and they walk all the distance visiting patients at their homes for 
the purpose of ensuring that the treatment is taken appropriately. 
3.5 Study population 
A population is the entire group of persons or objects that is of interest to the 
researcher, that meets the criteria which the researcher is interested in studying,The 
population that the researcher does have access to, and actually studies is known as 
study population(Brink, 2006: 123). 
The study population for this study was composed of all  the 42Community Health 
Workers, working at Chris Hani District as TB DOT supporters, which is composed of 
two sub- District, namely Tsolwana and InxubaYethemba in the Eastern cape. 
3.6 Sample and sampling procedure 
A sample is a part or fraction of a whole, selected by the researcher to participate in 
the research study. A sample thus consists of a selected group of the elements of 
analysis from a defined population (Brink, 2006: 124).A convenient sample of all  
the42 TB DOT supporters working in various clinics under Tsolwana and 
InxubaYethemba Sub-Districts was used for this study. 
3.7 The research instrument 
. The research instrument used in this study was designed by the researcher. 
Questionnaires were administered to the community health workers, working as TB 
DOT supporters at Chris Hani Municipality. The use of this tool provided the 
researcher with quantifiable data on TB DOT supporters’ perceptions of the 
effectiveness of TB DOT support programme offered at the clinic. 
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The instrument used was divided into the following sections: section1. Demographic 
data, which it dealt with their age, level of education and their marital status. Section 
two, was about the training they received and its duration, their understanding of the 
content and the salary they are receiving. Section three dealt with challenges in 
delivering of DOT Support programme. Section four was enquires about their 
interaction with clients during then executions of their duties. 
 
3.8 Validity and reliability of the instrument 
3.8.1 Validity 
Kumar (2005:153) defines the term validity as the ability of an instrument to measure 
what it is designed to measure. Content validity concerns “the degree to which an 
instrument has an appropriate sample of items for the construct being measured”(Polit 
and Beck 2012:236). Content validity for this study was ensured through the 
examination of the instrument by the researcher’s supervisors as well as a 
professional statistician from the University of Fort Hare. A pilot study was conducted 
to check if the questionnaire would give valid answers. Pre-testing of the instrument 
was done on respondents working at Philani Clinic. These respondents were not 
included in the study sample. The questionnaire provided an adequate representative 
sample of all content or elements of the phenomenon being measured. All items used 
in the questionnaire went through some form of validation, by checking the 
questionnaire for correct interpretation of the English language by an English expert.  
3.8.2 Reliability 
Kumar (2005:156) defines the concept of reliability as the consistency, stability, 
predictability and accuracy of the research instrument. The questionnaire used 
repeatedly must give constant similar results. To ensure reliability, a pilot study was 
conducted to ensure that the instrument is giving the same results as with other 
questionnaires used in similar studies. 
3.9 Pilot study 
The questionnaire was   pre tested with a small sample of respondents before use. 
The pilot check people’s understanding and ability to answer the questions highlight 
areas of confusion and look for any routing errors, as well as providing an estimate 
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of the average time each question will take to complete. Any amendments to the 
questionnaire were effected accordingly.  
3.10 Data collection method 
A self - administered questionnaire was used for this study. A questionnaire is a 
painted self report form designed to elicit what can be obtained through the written 
responses of the subjects (Burns and Groves, 2011:426).  The respondents were 
assembled in one central point in each of the sub- districts where the purpose and 
the objectives for conducting the study were given Respondents were allowed to 
read the permission letter before they could sign the consent form. The 
questionnaires were personally distributed by the researcher to TB DOT supporters.  
The questionnaires were all written in English as the participants understood the 
language. The researcher’s targeted sample was 42 participants although only 39 
filled in the questionnaires because three were on leave.  
3.11 Ethical consideration 
The study was conducted following the approval and issuing of the certificate by the 
University of Fort Hare Ethics Committee. Permission to conduct the study was 
obtained from the Eastern Cape Department of Health Research Ethics committee 
and from the Health management of Chris Hani District. The purpose of the study 
was explained to the participants in simple language. Participants were not 
pressurised into taking part in the research, and were informed that the participation 
is voluntary and that they were informed that they can   withdraw from the study at 
any point. Issues of confidentiality and anonymity and respect weremaintained 
throughout the study and no names appeared on the questionnaires. 
An informed consent was obtained from the participants after the nature, aim and the 
significance of the study had been clearly explained to them. Analysed data and 
other documents will be kept in a locked place. 
3.12 Data analysis 
The initial data analysis will be conducted by the author of this research study. Data 
will be entered on a spreadsheet according to variables Data was analysed using 
Microsoft excel 2007 andwas presented in the form of tables and graphs. 
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3.13Summary 
This chapter clearly describes the method and approach used in this study.  A clear 
picture of the study setting where the research took place is explained. 
Thequestionnaire, issues of reliability, reliability, ethical considerations and data 
analysis are described. 
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CHARPTER FOUR-RESULTS 
4.1 Introduction 
In this chapter the data has been analysed, and through analysis of the data the 
researcher tried to answer the following questions: Is the TB DOT support system 
effective in the improvement of adherence to TB treatment? What are the challenges 
encountered by TB DOT supporters? Is the increase in TB defaulters caused by 
fewer TB DOT supporters? 
This chapter presents analysis in the following sub-sections:  
 Demographic data of the clients 
 Training they received as TB DOT  supporters 
 Challenges encountered by TB DOT supporters that includes, distances they 
are walking when visiting clients, their salaries and Hours they are working. 
 Interaction with clients, including time they spend with clients, their 
acceptance by community members and the family and the support from the 
community. 
 Their knowledge and skills as far as TB is concerned. 
4.2 Clinic location and type 
A total of 21 clinics were visited during the study. Of the 21 clinics one was nullified 
because TB DOT supporters were on leave during the specific time of data 
collection. All the 21 clinics are situated at InxubaYethemba and Tsolwana Sub 
districts under Chris Hani District in the Eastern Cape 
4.3 Age of participant 
The results presented in the table below, are from a sample of 39 adults, working as 
TB DOT supporters. Out of 100% participants (n=39) 5.1% (n=2) ranges between 
20-29 years of age, 35.9% (n=14) ranges between 30-39 years of age, 48.7&% 
(n=19) ranges between 40-49 years of age, 10, 4% (n=4) ranges between 50-59 
years of age. 
 
Table 4.3 Age of participants 
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AGE RANGE Frequency Percentage 
20-29 2 5.1% 
 
30-39 
14 35.9% 
40-49 19 48.7% 
50-59 4 10.3% 
Total 39 100% 
 
4.4 Level of education 
Table 4.4 below shows TB DOT supporters’ level of education, of the 100% 
participants (n=39) 30.8% (n=12) are on grade 12, 43.6% (n=17) are on grade 11, 
12.8% (n=5) are on grade 10, 2, 6% (n=1) is on grade 6, 2.6% (n=1) has N6, 7.6% 
(n=3) have N4. 
 
Table 4. 4 Level of Education 
 N0 Percentage 
Grade   12 12 30.8% 
Grade 11 17 43.6% 
Grade 10 5 12.8% 
Grade 6 1 2.6% 
N6 1 2.6% 
N4 3 7.6% 
Totals 39 100% 
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4.5 Training of TB DOT Supporters 
 
Figure 4.1Training of TB DOT Supporters 
 TB DOT Supporters had undergone different trainings. Out of 100% (n=39), 59% 
(n=23) received a five days training, 12, 8% (n=5) received a three weeks training 
and 28, 2% (n=11) received a three days training. 
4.6 Challenges faced by TB DOT supporters 
4.6.1 Distance 
 
 
 
23 
5 
11 
0 
5 
10 
15 
20 
25 
5 day training  3 weeks 3 days 
4 
5 
9 
20 
0 
5 
10 
15 
20 
25 
4killometres 5 kilometres 8 kilometres 7 kilomitres 
32 
 
Figure4. 2 Distance travelled by DOT Supporters 
Figure4. 4 above shows the distances walked by TB DOT supporters when visiting 
clients. Of the 100% (n=39), 51.3% (n=20) walked 7 kilometers , 23% (n=9) walked 
8kilometers, 12,8% (n=5) walked 5kilometers and 10,2% (n=4) walked 4kilometers. 
4.6.2 Responses related salaries 
 
Figure 4.3 responses related to salaries of TB DOT Supporters 
Figure 4.3 above shows the responses given to TB DOT Supporters by the 
managers regarding their salaries. From the 100% (n=39) DOT Supporters 
interviewed, 64.1% (n=39) said they received no response from the government, 
20.5% (n=8) said they were told that they are volunteers, 10, 3% (n=4) said they 
were told that the Department doesn’t have money and 5.1% (n=2) said they were 
told that managers know nothing about them. 
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4.7 Acceptance of TB DOT supporters by the community 
 
 
Figure 4.4 Acceptance by the community 
The figure 4.4 above demonstrates the TB DOT Supporters were accepted by the 
community members. Of the 100% (n=39) TB DOT supporters interviewed, 82.1% 
(n=32) said that they were accepted by the community because they were known 
there, 5.1% (n=2) said that they were not accepted by the community because of the 
stigma attached with being visited by health workers, 5.1% (n=2) indicated that they 
were not accepted because they were coming too early to their houses, 2.6% (n=1) 
said that the clients were too ignorant regarding the DOT support programme. 
4.8 Knowledge and Skills 
Table 4.5 
 
 
 
Knowledge and skills Percentages 
Knowledge and skill  on 
how to give TB treatment 
100% (n=39) 
Able to list TB treatment 82.1% (n=32) 
Awareness of side effects 
of TB treatment 
82.1% (n=32) 
Use of protective masks 0% 
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4.9 Time spent with clients by TB DOT Supporters 
 
 
 
Figure 4.5 Time spent with the clients by TB DOT supporters 
The figure 4.5 above shows the time spent with the client by the TB DOT Supporters. 
Of the 100% (n=39) 59% (n=23) spent 30minutes, 23.1% (n=9) spent one hour, 
15.4%  
4.10 Summary 
The analysed results above   endeavoured to answer the following questions: Is the 
TB DOT Support system effective in the improvement of adherence to TB treatment? 
What are the challenges encountered by TB DOT supporters? Is the increase in the 
TB defaulters caused by fewer TB DOT Supporters? These results attempted to 
identify the relevancy and quality of training for DOT supporters at InxubaYethemba 
and Tsolwana sub-districts, identification of challenges faced by TB DOT supporters 
during the execution of their duties, and assessment of satisfaction by TB DOT 
supporters with their remuneration packages and other conditions of employment. 
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CHAPTR 5- DISCUSSION 
5.1 Introduction 
The purpose of this study was to assess the effectiveness of TB DOT Support 
programme in InxubaYethemba and Tsolwana sub-Districts. The challenges that are 
experienced by TB DOT Supporters are discussed as per results found in chapter 
four. 
In this chapter the analysed data is discussed under the following headings: 
Limitation of the study, demographic data including age, level of education and 
satisfaction with salary, Challenges in delivering of TB DOT support programme, 
knowledge and skills and the interaction with clients. 
5.2 Limitation of the study 
In considering findings in this study, it is important to bear in mind the following 
limitations: The results from this studycannot be generalised to the Eastern Cape, 
since only a convenient sample was used.  
There was so much delay in collecting data, the problem was with Chris Hani District 
management, who took more than three weeks to give permission for  data 
collection. 
5.3 Demographic data and representativeness 
In this section the demographic data will be discussed under the following topics: 
5.3.1 Clinic location and type 
A total of 21 clinics were visited in this study. Of the 21 clinics, one clinic was 
cancelled due to the fact that the TB DOT supporters in that particular clinic were on 
leave. 
In this particular clinic Community Health workerS are being used as TB DOT 
Supporters but not being trained as such. 
 
5.3.2 Gender Issues 
Of the 100% (n=39) interviewed, only 10.3% (n=4) were males. In one of the clinics a 
male DOT supporter is using his own bicycle for delivering of TB treatment to clients 
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and females cannot use bicycles according to their culture.So the fact that he is a 
maleworked to his advantage as he is using his bicycle as the mode of transport. 
5.3.3 Age group 
The age group of the TB DOT Supporters was between 20 and 59. The majority 
DOTs were between 40 and 49, 48.7 (n=17). This shows the level of knowledge and 
maturity on pyscho-social issues regarding challenges experienced by  the TB 
clients within the communities. 
5.3.4 Level of education 
Of the 100% (n=39) 44% (n=17) are on grade 11, which is the majority of the 
participants (TB DOT Supporters) This means that they are able to understand the 
concepts of TB as all the training is in English, and that they are also able to 
understand the concepts used in TB medication prevention and support programme.  
5.4 Training 
The training that the TB DOT Supporters received varied between three days and 
five weeks. Of the 100% (n=39) TB DOT Supporters 59% (n=23) received a 5 five 
days training, 12.8% (n=5) received five weeks training which are both in line with 
the Department of Health training manual guidelines 2007. Twenty eight point eight 
percentage (n=11) received a three days training. According to Dick and Murrey 
(2005:39) the training of TB DOT Supporters is supposed to be five days to five 
weeks, so the 11 TB DOT Supporters are being disadvantaged as far as the training 
of TB DOT is concerned.  
5.5 Challenges 
This section is divided into six sections, which are as follows: distance, availability of 
transport, hours worked by TB DOT Supporters, meetings held with the 
management, monthly salary and the fringe benefits 
5.5.1 Distance 
There is no public transport for home visits. TB DOT Supporters walk all the 
distances. The longest distance that they walk is 8km and the shortest is 4km, the 
norm is only 5km. Of the 100%) 23.1% (n=9) walk 8km, 51.3% (n=20) walk 7km, 
12.8% (n=5) walk 5km, 10.3% (n=4) walk 4km. 
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Considering hours they are working per week and distances they are travelling it is 
impossible for them to do quality home visits. According to SA Tuberculosis control 
Programme Practical guide, (2000: 33), Treatment Supporters observe patients as 
they swallow their drugs daily, with these distances it becomes impossible to do that, 
because at times when they arrive at these homes the clients have not eaten yet, so 
they have to wait to observe the client swallowing  the tablets.  
In other areas in InxubaYethemba and Tsolwana, there is a car that is used to give 
streptomycin to those clients who can not walk to the clinic due to illnesses, at times 
the car can not be available due to other commitments the district is dealing with and 
the clients do not get the streptomycin. When that happens, clients do not get the 
injection and that alone poses a danger not only to the clients but to the TB DOT 
Supporters as well, as the clients can develop MDR or XDR TB. 
5.5.2 Hours worked by TB DOT Supporters 
TB DOT Supporters work for four hours perday; this is according to their contract. 
The areas they are working in are so scattered from one another, with them walking 
long distances with up to eight clients per TB DOT Supporter it becomes impossible 
for them to reach all the clients each day or if they do reach all clients they do not 
deliver quality services. 
As the researcher, I would like to suggest for the department of Health to increase 
the number of hours worked by TB DOT Supporters, and add more trained 
community health workers working as TB DOT Supporters. 
5.5.3 Meeting held with the Management 
According to the interview done on the 21 clinics, all the 100% (n=39) TB DOT 
Supporters reported that no meetings were held in all the facilities with the 
managers. According to Dick and Murey (2005: 39) contact with the TB DOT 
Supporters and managers is supposed to be monthly. According to the responses  
from the TB DOT Supporters, it becomes difficult for the DOT Supporters to work 
without discussing their challenges with the management and that discourages them 
from doing their work properly. 
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5.5.4 Salaries 
All the TB DOT Supporters in the 21 clinics at InxubaYethemba and Tsolwana sub 
distriict are not happy with the salary they are receiving. Of the 100% (n=39), 64.1% 
(n=25) said that they got no response from the government regarding their salaries, 
20.5% (n=8), said that they were told that they are volunteers, they cannot make any 
demands, 10.3% (n=4) said that they were told that the Department of Health does 
not have money, 5.3% (n=2) reported that managers said they know nothing about 
their contract.In all the books and journals that I came across, there is nothing said 
by the Department of Health regarding their salaries. 
5.5.5 Fringe Benefits 
The 39 TB DOT Supporters that I interviewed at InxubaYethemba and Tsolwana 
sub-districts do not have fringe benefits. The majority of them (80%), in the cases of 
Medical Aid, they were told that they cannot be taken as members of the Medical 
Aid, as they are contract workers. When they enquired about the Unemployment 
Insurance Fund, no satisfactoryanswer was given. 
5.6 Acceptance of TB DOT Supporters by the community 
Results from TB DOTS Supporters regarding acceptance by members of the 
community indicated that they were accepted by the community members. Of the 
100% (n=39) TB DOT supporters who participated in the study, 82.1% (n=32) 
indicated that they were accepted by the community as  they were known by the 
community,  while 5.1% (n=2) said that they were not accepted by the community 
because of the stigma attached to them being visited by health workers in their 
homes. Five point one percent (n=2) said that they were not accepted by the 
community because they were coming too early to their homes,  while2,6% (n=1) 
said that the clients were too ignorant regarding DOT. Some of the TB DOT 
supporters were not accepted because of the lack of a proper introduction to the 
community members by their team leaders. According to Tuberculosis, A Training 
Manual for Health workers (1998: 72) a meeting should be set up with all 
stakeholders including representatives of different   community based organizations, 
governmental organizations, health forums, political structures, chiefs, indunas and 
other key people in the area to introduce the TB DOT Supporters. The main aim of 
the meeting is to gain entrance into the community. 
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5.7 Knowledge and skills 
All the participants seem to have been taught of the basics of TB, the causes of TB, 
how to prevent TB, MDR/ XDR TB. They were also aware of the TB treatment. Of 
the 100% (n=39) 82.1 %( n= 32) were able to list all the names of TB drugs. They 
know the kind of education to give to the clients. As far as their safety is concerned, 
they are given mask to wear when dealing with TB clients, but they are all not using 
those. They claim that clients feel stigmatised with them wearing masks and they 
also feel so uncomfortable with the masks, 
5.8 Time spent with the client 
It is difficult for TB DOT Supporters to spend a quality time with the clients, as the 
time allocated for them is very short. They are expected to work four hours, and the 
areas they are working in are so scatted. At times they do not visit all the houses, or 
if they do, proper education on certain issues is compromised, as they are rushing 
for other clients. 
Of the 100% (n=39) TB DOT Supporters interviewed, 59% (n=23) spent twenty 
minutes with the clients, while 23.1% (n=9) spent one hour with the clients, 15.4% 
(n=6) spent 15minutes with the clients and 2.6% (n=1) spent 10minutes with the 
clients  
5.9 Summary 
According to the results and discussions of this study, the effectiveness of TB DOT 
Supporters is being challenged by many factors, such as: not having transport for 
doing home visits, less number of hours worked per day, few number of community 
health workers working as TB DOT supporters, not having meetings with the 
management to discuss their challenges, and, most of all, not being given a clear 
explanation as far as their salaries are concerned. 
According to Tuberculosis, A training Manual proven for Health Workers (1998:13) 
the most effective means of controlling TB known to us is a strategy known as 
Directly Observed Treatment Short Course (DOTS). This strategy enables 
tuberculosis clients to complete their treatment. 
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With this information in mind, it is very important to empower TB DOT Supporters 
with more knowledge and skills so that they can be able to make an impact on the 
community. 
5.10 Recommendations 
The results from this research proves that there is a definite need for improvement of 
working conditions among TB Co-ordinators, TB Managers and the TB DOT 
Supporters. It is clear that increased number of MDR/XDR is due to the challenges 
that I have mentioned above.  The Department of Health, District Managers should 
ensure  that additional numbers of TB DOT Supporters are provided, as the area is 
big for only two TB DOT Supporters in each area. Hours worked by TB DOT 
supporters and their salaries need some serious consideration. Monthly meetings 
with the managements are also recommended so as to discuss the challenges DOT 
supporters have and also just  to motivate and encourage them. The Department of 
Health must provide the districts with the cars to do home visits and to give 
streptomycin to bedridden clients so as to prevent MDR/XDR TB  
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